Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Authors
Keywords
-
Journal
INTENSIVE CARE MEDICINE
Volume 45, Issue 10, Pages 1360-1371
Publisher
Springer Science and Business Media LLC
Online
2019-10-02
DOI
10.1007/s00134-019-05704-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Checkpoint Inhibition in Sepsis
- (2019) Richard S. Hotchkiss et al. CRITICAL CARE MEDICINE
- Novel Interventions
- (2018) Jean-Louis Vincent et al. CRITICAL CARE CLINICS
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence for Persistent Immune Suppression in Patients Who Develop Chronic Critical Illness After Sepsis
- (2018) Julie A. Stortz et al. SHOCK
- Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study
- (2017) Estelle Peronnet et al. INTENSIVE CARE MEDICINE
- Prognostic Accuracy of the SOFA Score, SIRS Criteria, and qSOFA Score for In-Hospital Mortality Among Adults With Suspected Infection Admitted to the Intensive Care Unit
- (2017) Eamon P. Raith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014
- (2017) Chanu Rhee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
- (2017) David Grimaldi et al. LANCET INFECTIOUS DISEASES
- Advances in the understanding and treatment of sepsis-induced immunosuppression
- (2017) Fabienne Venet et al. Nature Reviews Nephrology
- Cytokine storm and sepsis disease pathogenesis
- (2017) Benjamin G. Chousterman et al. Seminars in Immunopathology
- Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
- (2016) Carolin Fleischmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
- (2016) Andriani C. Patera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study
- (2016) Emma E Davenport et al. Lancet Respiratory Medicine
- Up-regulation of Programmed Cell Death 1 Ligand 1 on Neutrophils May Be Involved in Sepsis-induced Immunosuppression
- (2015) Jia-Feng Wang et al. ANESTHESIOLOGY
- Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients
- (2015) P. E. Vulliamy et al. European Journal of Trauma and Emergency Surgery
- Timing and causes of death in septic shock
- (2015) Fabrice Daviaud et al. Annals of Intensive Care
- Hospital Deaths in Patients With Sepsis From 2 Independent Cohorts
- (2014) Vincent Liu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality
- (2014) Anne M. Drewry et al. SHOCK
- Why have clinical trials in sepsis failed?
- (2014) John C. Marshall TRENDS IN MOLECULAR MEDICINE
- Reduction of Immunocompetent T Cells Followed by Prolonged Lymphopenia in Severe Sepsis in the Elderly*
- (2013) Shigeaki Inoue et al. CRITICAL CARE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples
- (2012) Julie Demaret et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started